Interferon- Release Assays Improve the Diagnosis of Tuberculosis and Nontuberculous Mycobacterial Disease in Children in a Country with a Low Incidence of Tuberculosis
Clinical Infectious Diseases2007Vol. 45(3), pp. 322–328
Citations Over TimeTop 1% of 2007 papers
Abstract
Both IGRAs showed high diagnostic value in bacteriologically confirmed childhood TB. Their advantage in this study, when performed in addition to the TST, was the ability to distinguish -positive TST results caused by nontuberculous mycobacterial disease, thereby reducing overdiagnosis of TB and guiding clinical management.
Related Papers
- → Tuberculin Skin Testing and Treatment Modulates Interferon-Gamma Release Assay Results for Latent Tuberculosis in Migrants(2014)27 cited
- → Validation and clinical application of interferon-gamma release assay for diagnosis of latent tuberculosis infection in children(2019)12 cited
- → Tuberculin Test versus Interferon Gamma Release Assay in Pregnant Women with Household Contacts of Tuberculosis Patients(2022)4 cited
- interferon-g amma-release assay Prevents unnecessary t uberculosis therapy(2015)
- Re: Interferon-gamma Release Assay Agreement With Tuberculin Skin Test in Pretransplant Screening for Latent Tuberculosis in a High-prevalence Country(2014)